188 related articles for article (PubMed ID: 16138320)
1. [(11)C]MADAM, a new serotonin transporter radioligand characterized in the monkey brain by PET.
Halldin C; Lundberg J; Sóvágó J; Gulyás B; Guilloteau D; Vercouillie J; Emond P; Chalon S; Tarkiainen J; Hiltunen J; Farde L
Synapse; 2005 Dec; 58(3):173-83. PubMed ID: 16138320
[TBL] [Abstract][Full Text] [Related]
2. Quantification of 11C-MADAM binding to the serotonin transporter in the human brain.
Lundberg J; Odano I; Olsson H; Halldin C; Farde L
J Nucl Med; 2005 Sep; 46(9):1505-15. PubMed ID: 16157534
[TBL] [Abstract][Full Text] [Related]
3. A radiometabolite study of the serotonin transporter PET radioligand [(11)C]MADAM.
Gourand F; Emond P; Bergström JP; Takano A; Gulyás B; Guilloteau D; Barré L; Halldin C
Nucl Med Biol; 2014 Jul; 41(6):501-6. PubMed ID: 24857865
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
Jarkas N; McConathy J; Votaw JR; Voll RJ; Malveaux E; Camp VM; Williams L; Goodman RR; Kilts CD; Goodman MM
Nucl Med Biol; 2005 Jan; 32(1):75-86. PubMed ID: 15691664
[TBL] [Abstract][Full Text] [Related]
5. Validation of two fluoro-analogues of N,N-dimethyl-2-(2'-amino-4'-hydroxymethyl-phenylthio)benzylamine as serotonin transporter imaging agents using microPET.
Jarkas N; Voll RJ; Williams L; Goodman MM
Nucl Med Biol; 2010 Jul; 37(5):593-603. PubMed ID: 20610164
[TBL] [Abstract][Full Text] [Related]
6. [(11)C]PE2I: a highly selective radioligand for PET examination of the dopamine transporter in monkey and human brain.
Halldin C; Erixon-Lindroth N; Pauli S; Chou YH; Okubo Y; Karlsson P; Lundkvist C; Olsson H; Guilloteau D; Emond P; Farde L
Eur J Nucl Med Mol Imaging; 2003 Sep; 30(9):1220-30. PubMed ID: 12811422
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of N,N-dimethyl-2-(2-amino-4-methylphenyl thio)benzylamine as a ligand of the serotonin transporter with high affinity and selectivity.
Chalon S; Tarkiainen J; Garreau L; Hall H; Emond P; Vercouillie J; Farde L; Dasse P; Varnas K; Besnard JC; Halldin C; Guilloteau D
J Pharmacol Exp Ther; 2003 Jan; 304(1):81-7. PubMed ID: 12490578
[TBL] [Abstract][Full Text] [Related]
8. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
[TBL] [Abstract][Full Text] [Related]
9. Measurement of serotonin transporter binding with PET and [11C]MADAM: a test-retest reproducibility study.
Lundberg J; Halldin C; Farde L
Synapse; 2006 Sep; 60(3):256-63. PubMed ID: 16752362
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vivo evaluation of halogenated N,N-dimethyl-2-(2'-amino-4'-hydroxymethylphenylthio)benzylamine derivatives as PET serotonin transporter ligands.
Jarkas N; Voll RJ; Williams L; Votaw JR; Owens M; Goodman MM
J Med Chem; 2008 Jan; 51(2):271-81. PubMed ID: 18085744
[TBL] [Abstract][Full Text] [Related]
11. Carbon-11 HOMADAM: a novel PET radiotracer for imaging serotonin transporters.
Jarkas N; Votaw JR; Voll RJ; Williams L; Camp VM; Owens MJ; Purselle DC; Bremner JD; Kilts CD; Nemeroff CB; Goodman MM
Nucl Med Biol; 2005 Apr; 32(3):211-24. PubMed ID: 15820756
[TBL] [Abstract][Full Text] [Related]
12. The new PET imaging agent [11C]AFE is a selective serotonin transporter ligand with fast brain uptake kinetics.
Zhu Z; Guo N; Narendran R; Erritzoe D; Ekelund J; Hwang DR; Bae SA; Laruelle M; Huang Y
Nucl Med Biol; 2004 Nov; 31(8):983-94. PubMed ID: 15607480
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo characterisation of nor-beta-CIT: a potential radioligand for visualisation of the serotonin transporter in the brain.
Bergström KA; Halldin C; Hall H; Lundkvist C; Ginovart N; Swahn CG; Farde L
Eur J Nucl Med; 1997 Jun; 24(6):596-601. PubMed ID: 9169564
[TBL] [Abstract][Full Text] [Related]
14. Effect on [11C]DASB binding after tranylcypromine-induced increase in serotonin concentration: positron emission tomography studies in monkeys and rats.
Lundquist P; Roman M; Syvänen S; Hartvig P; Blomquist G; Hammarlund-Udenaes M; Långström B
Synapse; 2007 Jun; 61(6):440-9. PubMed ID: 17372973
[TBL] [Abstract][Full Text] [Related]
15. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
[TBL] [Abstract][Full Text] [Related]
16. Temperament, character and serotonin activity in the human brain: a positron emission tomography study based on a general population cohort.
Tuominen L; Salo J; Hirvonen J; Någren K; Laine P; Melartin T; Isometsä E; Viikari J; Cloninger CR; Raitakari O; Hietala J; Keltikangas-Järvinen L
Psychol Med; 2013 Apr; 43(4):881-94. PubMed ID: 22850434
[TBL] [Abstract][Full Text] [Related]
17. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
Lemoine L; Lieberman BP; Ploessl K; Zheng P; Kung HF
Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117
[TBL] [Abstract][Full Text] [Related]
18. A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.
Lundberg J; Borg J; Halldin C; Farde L
Psychopharmacology (Berl); 2007 Dec; 195(3):425-33. PubMed ID: 17874074
[TBL] [Abstract][Full Text] [Related]
19. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
Pike VW; Halldin C; McCarron JA; Lundkvist C; Hirani E; Olsson H; Hume SP; Karlsson P; Osman S; Swahn CG; Hall H; Wikström H; Mensonidas M; Poole KG; Farde L
Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
[TBL] [Abstract][Full Text] [Related]
20. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
Shiue GG; Choi SR; Fang P; Hou C; Acton PD; Cardi C; Saffer JR; Greenberg JH; Karp JS; Kung HF; Shiue CY
J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
